Apple
AAPL
Cisco
CSCO
Disney
DIS
Qualcomm
QCOM
Taiwan Semiconductor
TSM
US Stock MarketDetailed Quotes
BMY Bristol-Myers Squibb
- 60.990
- +0.970+1.62%
Close Mar 31 16:00 ET
- 60.900
- -0.090-0.15%
Post 20:01 ET
124.10BMarket Cap-13.83P/E (TTM)
61.640High59.370Low11.62MVolume59.800Open60.020Pre Close708.64MTurnover0.57%Turnover RatioLossP/E (Static)2.03BShares63.33052wk High7.60P/B123.86BFloat Cap38.18252wk Low2.42Dividend TTM2.03BShs Float74.028Historical High3.97%Div YieldTTM3.78%Amplitude8.199Historical Low61.004Avg Price1Lot Size
About Bristol-Myers Squibb Company
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.
Company Profile
SymbolBMY
Company NameBristol-Myers Squibb
Listing DateJun 1, 1969
Issue Price40.50
Founded1933
CEODr. Christopher S. Boerner, PhD
MarketNYSE
Employees34100
Fiscal Year Ends12-31
AddressRoute 206 & Province Line Road
CityPrinceton
ProvinceNew Jersey
CountryUnited States of America
Zip Code08543
Phone1-609-252-4621
Websitehttp://www.bms.com
Company Executives
- Name
- Position
- Salary
- Dr. Christopher S. Boerner, PhD
- Chairman of the Board and Chief Executive Officer
- 18.79M
- Amanda Ahn Poole
- Executive Vice President and Chief People Officer
- --
- Gregory Scott Meyers
- Executive Vice President, Chief Digital Officer and Chief Technology Officer
- --
- David V. Elkins
- Executive Vice President and Chief Financial Officer
- 8.71M
- Adam Lenkowsky
- Executive Vice President and Chief Commercialization Officer
- --
- Dr. Samit Hirawat, M.D.
- Executive Vice President, Chief Medical Officer and Head of Development
- 8.59M
- Dr. Robert M. Plenge, M.D.,PhD
- Executive Vice President, Chief Research Officer and Head of Research
- --
- Phil Holzer
- Senior Vice President, Principal Accounting Officer and Controller
- --
- Karin Shanahan
- Executive Vice President, Global Product Development and Supply
- 6.57M
- Cari Gallman
- Executive Vice President, Corporate Affairs
- --
- Sandra Leung
- Executive Vice President and General Counsel
- 7.01M
- Lynelle Hoch
- President, Cell Therapy Organization
- --
- Benjamin J. Hickey, M.B.A.
- President, RayzeBio Organization
- --
- Phyllis R. Yale
- Independent Director
- 380.00K
- Paula A. Price
- Independent Director
- 380.00K
- Theodore R. Samuels
- Lead Independent Director
- 440.00K
- Peter J. Arduini
- Independent Director
- 376.79K
- Michael R. McMullen
- Independent Director
- 185.86K
- Derica W. Rice
- Independent Director
- 390.00K
- Dr. Manuel Hidalgo Medina, M.D.,PhD
- Independent Director
- 350.00K
- Dr. Karen H. Vousden, PhD
- Independent Director
- 350.00K
- Dr. Julia A. Haller, M.D.
- Independent Director
- 390.00K
- Dr. Deepak L. Bhatt, M.D.,M.P.H.
- Independent Director
- 350.00K
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
